GFAP and coronary artery disorder: An integrated biomarker panel, consisting of ST2, Gal-3, glial fibrillary acidic protein (GFAP) and NT-proBNP, can constitute a relevant addition to clinical data in predicting the 30-day and one-year rehospitalization and mortality rates in children undergoing surgery for CHD [104,105,106].